Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
StateWatch: Bill Review August / September 2018
Keep current with new legislation and its potential effect on your organization.
Implications of Epidiolex FDA Approval on Workers' Compensation
In June 2018, the Federal Drug Administration (FDA) approved Epidiolex, the first plant-derived cannabinoid medicine in the United States. With several states already moving toward legalization of medical marijuana, this is a major step for the federal government.
How Differences in Claim Age and Population Affect Opioid Trends
Management of opioid therapy can be influenced by the types of drugs filled, differing patient populations, and the nature of the injury. Don’t miss our latest video blog where we will review some of the differences that point to the importance of early intervention and identification of long term risk.
Illinois Piloting Opioid Alternative Cannabis Program
The Illinois Alternatives to Opioids Act of 2018 recently went into effect. Learn what this means for workers' compensation patients.
Vermont Department of Labor Proposes Rule Incorporating Opioid Prescribing Guidelines
By Brian Allen, VP of Government Affairs
Vermont Department of Labor Proposes Rule Incorporating Opioid Prescribing Guidelines
The Vermont Department of Labor has proposed a rule that would, by reference, incorporate the Department of Health opioid prescribing guidelines fo